Published July 2, 2021
| Version v1
Journal article
Open
Antibody Characterization Report for Superoxide dismutase [Cu-Zn] (SOD1)
Creators
- 1. Montreal Neurological Institute
Description
Head to head comparison of available commercial antibodies against Superoxide dismutase [Cu-Zn] (SOD1) by immunoblot (Western blot), immunoprecipitation and immunofluorescence. The workflow and data collected in this study was used to create an article published on F1000, DOI: 10.12688/f1000research.132952.2.
This work is part of the ALS-Reproducible Antibody Platform (ALS-RAP). ALS-RAP was created as a public-private partnership by three leading ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.
Files
Superoxide dismutase [Cu-Zn]_SOD1-YCharOS report.pdf
Files
(2.5 MB)
Name | Size | Download all |
---|---|---|
md5:7a7e6026113f4136a9ada9d774cf6c20
|
2.5 MB | Preview Download |